Bariatric Surgery for Severe Obesity Markedly Improves Cardiometabolic Health
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 20, 2024 -- Metabolic surgery for the treatment of severe obesity leads to considerable cardiometabolic improvements, according to a study published online March 14 in the Journal of the Endocrine Society.
Lei Wang, from the Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues examined cardiometabolic improvements after metabolic surgery in a large multiracial cohort, with 7,804 patients (aged 20 to 79 years; median body mass index, 46.4 kg/m2) undergoing first-time metabolic surgery from 1999 to 2022.
Most of the patients were women (1,618 men) and White (1,271 Black). The researchers found that patients had significant decreases in systolic blood pressure (10.5 mm Hg), total cholesterol (13.5 mg/dL), glucose (13.6 mg/dL), hemoglobin A1c (1.13 percent), and 10-year atherosclerotic cardiovascular disease (ASCVD) risk (absolute reduction, 1.58 percent; relative reduction, 34.4 percent) at one year after surgery. Less reduction in the 10-year ASCVD risk and lower odds of diabetes/hypertension/dyslipidemia remission were seen for older, male, or Black patients versus younger, female, or White patients. Fewer cardiometabolic improvements were seen for patients with a history of diabetes, hypertension, dyslipidemia, or cardiovascular disease than those without. Similar results were seen with or without further adjustment for weight loss, and they were mostly sustained two years postoperatively.
"Our study highlights how bariatric surgery not only leads to significant weight loss but also substantially improves heart health," Wang said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults
WEDNESDAY, May 22, 2024 -- For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research...
Fish Oil Beneficial for Reducing Risk for Cardiovascular Disease Progression
WEDNESDAY, May 22, 2024 -- The role of regular use of fish oil supplements varies for people with and without cardiovascular disease, according to a study published online May 21...
Ultraprocessed Foods Increase Adiposity, Cardiometabolic Risk in Children
WEDNESDAY, May 22, 2024 -- High ultraprocessed food (UPF) consumption in young children is associated with adiposity and other cardiometabolic risk factors, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.